Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rexin-G, a targeted genetic medicine for cancer.

Expert opinion on biological therapy - 1 May 2010

Gordon Erlinda M, Hall Frederick L

Abstract excerpt

IMPORTANCE OF THE FIELD: Rexin-G, a tumor-targeted retrovector bearing a cytocidal cyclin G1 construct, is the first targeted gene therapy vector to gain fast track designation and orphan drug priorities for multiple cancer indications in the US. AREAS COVERED IN THIS REVIEW: This review describes the major milestones in the clinical development of Rexin-G: from the molecular cloning and characterization of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Evidence-Based Medicine
Share to Genetic Therapy
Share to Genetic Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Share to Proto-Oncogene Mas

Share to Treatment Outcome

Source

Identifiers

PMID: 20384524
DOI: 10.1517/14712598.2010.481666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rexin-G, a targeted genetic medicine for cancer.PMID 20384524Read ↗

Gene Therapies for Cancer: Strategies, Challenges and Successes.Semantic proximity Read ↗

Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic CancerSemantic proximity Read ↗

Gene Therapy Used in Cancer TreatmentSemantic proximity Read ↗

Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus VectorsSemantic proximity Read ↗

Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory GuidelinesSemantic proximity Read ↗

Gene therapy for cancer: regulatory considerations for approvalSemantic proximity Read ↗

Gene Editing and Gene Therapy: Entering Uncharted Territory in Veterinary OncologySemantic proximity Read ↗

Regulation of CAR transgene expression to design semiautonomous CAR-TSemantic proximity Read ↗

An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other CancersSemantic proximity Read ↗

BJCP-EMA commentaries on the guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells.Semantic proximity Read ↗

Gene therapy in cancerSemantic proximity Read ↗

EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.